BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Office of Research - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.med.unc.edu/oor
X-WR-CALDESC:Events for Office of Research
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220621T170000
DTEND;TZID=America/New_York:20220621T170000
DTSTAMP:20260623T081005
CREATED:20220505T161629Z
LAST-MODIFIED:20220505T161629Z
UID:10000934-1655830800-1655830800@www.med.unc.edu
SUMMARY:Limited Submission Internal Deadline: Pathway to Stop Diabetes Award
DESCRIPTION:Limited Submissions: Internal Call for Proposals \nPathway to Stop Diabetes Award \nUNC Internal Deadline: 11:59PM\, Tuesday\, June 21\, 2022  \n  \n*Please distribute to relevant faculty* \nKey Dates \nUNC Internal Deadline: 11:59pm\, Tuesday\, June 21\, 2022 \nFull Application Deadline: August 1\, 2022  \nImportant Information \nNumber of applications per institution: One per category. \nAward Information \nInitiator Award (INI): Awards provide two distinct phases of research support: Phase 1 provides up to two years of support for mentored training at a maximum of $100\,000 per year (including 10% indirect costs)\, Phase 2 provides up to five years of support for independent research at a maximum of $325\,000 per year (including 30% indirect costs). Maximum combined support for Phase 1 and Phase 2 is $1\,625\,000. \nMaximum Funding: Up to $100\,000/year in Phase 1\, Up to $325\,000/year in Phase 2 \nSupport: Project support & PI salary\nIndirect Support: Up to 10% of directs in Phase 1\, Up to 30% of directs in Phase 2\nProject % Effort Required: 75-100% effort in Phase 1\, 50-75% effort in Phase 2 \nAccelerator Award (ACE): Awards provide five years of research support at a maximum of $325\,000 per year (including 30% indirect costs)\, for a total of $1\,625\,000. \nMaximum Funding: $325\,000/year\nSupport: Project support & PI salary\nIndirect Support: Up to 30% of directs\nProject % Effort Required: 25-50% effort \n  \nTo Apply \nSubmit the following as attachments via LAMSeS by 11:59PM\, Tuesday\, June 21\, 2022. \n\nLetter of Recommendation from Department Chair \nPI’s NIH-formatted biosketch – co-PI biosketches may be included but are not required. \nProject description + Award Category (INI or ACE) (up to 2-pages)\nList of potential collaborators (internal and external to UNC) \nNames of three internal (to UNC) experts who could speak knowledgeably about the candidate’s research and who could potentially serve on an internal review panel. \n\nPlease do not include the names of faculty named on the project\, chairs\, deans\, directors\, direct reports\, or others who have a conflict of interest.\nPlease notify all potential internal reviewers before submitting the pre-proposal packet to ORD.\n\n\n\nProgram Overview \nThis call for nominations will prioritize translational applications that move knowledge and discovery gained from basic research to its eventual translation into patient and population benefit. The ideal applicant will propose innovative research that will be an important step towards the eventual goal of improving the lives of people at risk of diabetes or living with the disease – and the pathway to this impact is clear. Our vision is to create a pathway to launch the next generation of trailblazers in diabetes research. \n  \nPathway to Stop Diabetes has a simple\, yet revolutionary goal: to find scientists at the peak of their creativity and provide them with the flexibility and resources they need on the road to breakthrough discoveries. We attract and retain brilliant scientists in diabetes. Our three areas of focus—awarding research grants\, providing access to scientific and career mentoring from leading diabetes researchers\, and creating a diabetes think tank—are each key components of a unique formula to cultivate the next generation of leaders\, whose discoveries will stop diabetes and all of its burdens once and for all. \n  \nTo accelerate the research needed to stop this deadly disease\, the American Diabetes Association’s bold transformational initiative\, Pathway to Stop Diabetes\, is inspiring a new generation of diabetes researchers. Pathway provides crucial support to individuals focusing on innovative ideas and transformational approaches that will lead to ground-breaking discoveries in diabetes prevention\, management and cures. We are building a human pathway to tackle the toughest questions in diabetes by driving research innovations through 1:1 mentorship and the creation of a brain trust in diabetes. \n  \nInitiator Award (INI): This two-phased award is designed to support the transition of scientists from mentored training to independent research faculty. \n  \nAccelerator Award (ACE): This award is designed to support exceptional\, independent early-career researchers who have distinguished themselves as promising investigators and are in the beginning stages of establishing successful\, sustainable diabetes research programs. \n  \nEligibility \nInitiator Award (INI): Eligible applicants must currently be in research training positions (post-doctoral fellow\, research fellowship) and have no more than seven years of research training following terminal doctoral degree. Applicants cannot concurrently hold an NIH K99/R00 grant. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.  \nApplicant: Postdoctoral Fellow \nAward Term: Up to 7 years\nCitizenship: Authorized to work in U.S. or U.S. possessions \n  \nAccelerator Award (ACE): Awards are available to early-career diabetes investigators proposing innovative and ambitious diabetes-related research programs. Applicants must hold faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K\, U or R awards\, including an initial R01/U01) but must not have applied for (regardless of outcome)\, or received\, an R01/U01 renewal or a second R01/U01 award. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.  \nApplicant: Early Career Faculty  \nAward Term: Up to 5 years\nCitizenship: Authorized to work in U.S. or U.S. possessions  \n  \nReview Criteria \nThe internal review criteria will mirror the guidelines as described within the full program announcement alongside the standard NIH criteria below.  \nProposal’s responsiveness to program criteria: How well the proposal addresses the program’s stated goals? How well does the nominee meet the foundation’s criteria? \nPresentation of the proposal: Is the proposal well-written and easily understood? Does it anticipate\, and address potential areas of weakness? \nNominee: Address the qualifications and research experience of the nominee. What is their stature in the academic community? Are they well-qualified based on the criteria? Share what is most significant (based on the foundation’s criteria) about the nominee’s publication experience\, funding history\, how they have made a significant contribution to science/scholarship? \nImpact of the proposal and potential benefit to the university: Will the proposal make a significant impact on the academic field involved? To society? Will it advance the state-of-the-art in its field? How will the university community benefit if the proposal were funded? \nAdditional Information \nComplete Program Announcement  \n  \nFor additional information\, please contact the Limited Submissions Team with questions at Limited_Submission@unc.edu. \n  \n  \n  \nLimited Submissions Team \nOffice of Research Development \nUniversity of North Carolina at Chapel Hill \n 
URL:https://www.med.unc.edu/oor/event/limited-submission-internal-deadline-pathway-to-stop-diabetes-award/
END:VEVENT
END:VCALENDAR